Neuracle Medical Technology is the developer of the NEO brain-computer interface system, which in March 2026 became the first invasive BCI to receive regulatory approval for commercial use anywhere in the world. China's National Medical Products Administration granted a Class III medical device certificate for the NEO system, which helps patients with quadriplegia caused by cervical spinal cord injuries regain limited hand function. The coin-sized implant uses 8 epidural electrodes to record brain signals when a patient imagines moving their hand, decoded by computer to control a pneumatic robotic glove. The device is battery-free, powered wirelessly via magnetic coil. Clinical trials involving 36 participants showed improvements in hand grasping ability with signs of neural remodeling.